Curriculum Vitae Michalis (Michael) V. Karamouzis - MyLoyalCard

59) M.V. Karamouzis, G. Ioannidis & G. Rigatos: “Quality of life in metastatic breast
cancer patients under chemotherapy or supportive care: a single-institution
comparative study”, Eur J Cancer Care, 16: 433-438, 2007.
60) A. Argiris, S. Agarwala, M.V. Karamouzis, L.A. Burmeister & S.E. Carty: “A
phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary
thyroid cancer, Invest New Drugs, 2007.
61) M.V. Karamouzis, P.A. Konstantinopoulos & A.G. Papavassiliou: “Trastuzumab
– Mechanism of action and use in clinical practice”, New Engl J Med, 357: 1664,
2007.
62) M.V. Karamouzis & A. Argiris: “Update on the role of EGFR inhibitors in cancer
therapeutics”, Cancer Treat Res, 135: 257-275, 2007.
63) P.A. Konstantinopoulos, G.P. Vandoros, M.V. Karamouzis, M. Gkermpesi, G.
Sotiropoulou-Bonikou & A.G. Papavassiliou: “EGF-R is expressed and AP-1 and
NF-KB are activated in stromal myofibroblasts surrounding colon
adenocarcinomas paralleling expression of cyclooxygenase-2 and VEGF”, Cell
Oncol, 29: 477-482, 2007.
64) M.V. Karamouzis, A. Argiris & J.R. Grandis: “Clinical applications of gene
therapy in head and neck cancer”, Curr Gene Ther, 7: 446-457, 2007.
65) P.A. Konstantinopoulos, M.V. Karamouzis, A.G. Papatsoris & A.G.
Papavassiliou: “Matrix metalloproteinase inhibitors as anticancer agents”, Int J
Biochem Cell Biol, 40: 1156-1168, 2007.
66) A. Argiris, M.V. Karamouzis, J. Johnson, D.E. Heron, D. Eibling, E. Cano, S.
Urba, J, Gluckman Y. Wang & S. Agarwala: “A phase III randomized trial of
postoperative radiotherapy with or without carboplatin in patients with high risk,
locally advanced squamous cell carcinoma of the head and neck”, Laryngoscope,
118: 444-449, 2007.
67) M.V. Karamouzis, P.A. Konstantinopoulos, F.A. Badra & A.G. Papavassiliou:
“SUMO and estrogen eceptors in breast cancer”, Breast Cancer Res Treat, 107:
195-210, 2008.
68) P.A. Konstantinopoulos, M.V. Karamouzis & A.G. Papavassiliou:
“Thaizolidinediones and cardiovascular events: Is concomitant aspirin use a
confounder?”, JAMA, 299: 1539, 2008.
8
8